Gene Query: NUP155

Dataset Description Geneva Score
ncRNA (non-coding RNA) signature in endothelial cells during hypoxia [RNA-seq] 38.32
ncRNA (non-coding RNA) signature in endothelial cells during hypoxia 38.32
RIG-I and MDA5 fRIP during KSHV lytic reactivation 33.31
Nm-seq finds thousands of modified 2’-O-methylation sites in mRNA with base precision 29.94
RNA-Seq analysis RPE1 cells following exposure to Nutlin-3 to identify target genes of p53 [tpo12] 27.47
ETV7 and interferon response 26.07
Impact of ETV7 activity on interferon-stimulated gene expression in 293T cells treated with interferon alpha 26.07
microRNA suppresses prostate cancer stem cells and metastasis by inhibiting a cohort of pro-metastasis targets including CD44, Rho GTPases and EZH2 25.44
RNA-Seq analysis of 4N and 2N RPE1 cells following polyploid induction via cytokinesis failure or Aurora kinase inhibition [tpo3] 25.13
Alu RNA modulates the expression of cell cycle genes in human fibroblasts 24.13
Genes significantly down or Up-regulated upon RNF219 knockdown 23.86
m6A-seq data analysis of control and PCIF1 knockdown transcriptome 23.73
Enriched EWSR1 and EWS-FLI1 RNA-seq of HNRNPH1-silenced TC32 Ewing sarcoma and 293T human embryonic kidney cells. 23.44
LNCaP treated with iBET 22.0
TGF-β regulation of miRNA expression in pancreatic cancer 21.29
Homolog-selective degradation as a strategy to probe the function of CDK6 in AML 21.05
Presence of NAD+-capped RNA in human cells: function and removal by the DXO deNADing Protein 20.9
Supraphysiological Androgens Repress Prostate Cancer Growth and Induce DNA Damage Augmented by PARP Inhibition 20.8
24hr CA treatment vs. DMSO in HCT116 cells (from 'Identification of CDK8 and CDK19 substrates in human cells using cortistatin A and quantitative phosphoproteomics') 20.61
The landscape of alternative splicing in aggressive prostate cancers 20.01
MiR-CLIP capture of a miRNA targetome uncovers a lincRNA H19-miR-106a interaction 19.95
A role for p53 in the adaptation to glutamine starvation through the expression of Slc1a3 19.91
miCLIP, RNA-Seq, and Ribo-Seq in MOLM13 cells 19.87
HDAC inhibition enhances the in vivo efficacy of MEK inhibitor therapy in uveal melanoma 19.71
Transcriptome analysis of total RNA in human osteosarcoma cell line U2OS before and after inhibition of zinc finger protein ZNF768 19.68
RNAseq Analysis in glioblastoma cells treated with Mepazine 19.54
Transcriptomic profiling of O-GlcNAcylated mRNA-protein complexes by using OG-CLAP in HeLa cells. 19.2
Poly(ADP-ribosyl)ation dependent changes in CTCF-chromatin binding and gene expression in breast cells 19.17
Transcriptomic analysis of cultured corneal endothelial cells as a validation for their use in cell-replacement therapy 18.92
Role of microRNAs in the interaction between Salmonella and the host cell 18.86
MYCi361 regulates MYC target genes 18.67
Transcriptomic Reprogramming of Prostate Cancer Cells Driven by Stroma-Derived SPINK1 18.44
Transcriptomics-based drug repurposing approach identifies novel drugs against sorafenib-resistant hepatocellular carcinoma 18.3
Ribosomal footprinting of CN34-Parental and CN34-LM1a 18.26
CDK12 catalytic activity is rate-limiting for RNAPII processivity on core DNA replication genes and G1/S progression (nuclear RNA) 18.21
A Unique Epigenomic Landscape Defines Human Erythropoiesis 17.87
A Unique Epigenomic Landscape Defines Human Erythropoiesis (RNA-seq) 17.87
RNAseq of HEK293 cells after Chtop knockdown 17.76
Co-transcriptional loading of RNA export factors shapes the human transcriptome 17.76
Human iPSC derived glomeruli facilitate accurate modelling of podocytopathy 17.51
Proliferation pause as an early blockade of human cellular reprogramming toward pluripotency [RNA-seq analysis] 17.47
A novel CRISPR-engineered prostate cancer cell line defines the AR-V transcriptome and identifies PARP inhibitor sensitivities. 17.34
Sequencing of messenger RNAs with N6-methyladenosine modifications in acute myeloid leukemia (AML) with and without forced expression of FTO 17.31
The myelin protein PMP2 is regulated by SOX10 and drives melanoma cell invasion 17.01
Convergent exaptation of Alu and B/ID SINEs for Staufen-mediated mRNA decay 16.87
Human Adipocytes Regulate Gene Expression in Triple-negative Breast Cancer Assessed by NGS Sequencing 16.81
Global transcriptional profiling changes upon knockdown of G9a in human non-small cell lung cancer cells 16.76
RNA-Seq to assess the transcriptional effects of G quadruplex stabilization by the G4 ligand PhenDC3 in HT-1080 cells 16.61
The role of PHF19 in promoting H3K27me3 deposition in multiple myeloma 16.48
The role of PHF19 in promoting H3K27me3 deposition in multiple myeloma (RNA-Seq) 16.48
Identifying transcripts that are transcriptinoally regulated by CBFB and RUNX1 using RNAseq 16.15
Selectively targeting bromodomain and extraterminal proteins for degradation as a novel anti-glioblastoma strategy [RNA-seq] 16.09
Acetylation-Dependent Control of Global Poly(A) RNA Degradation by CBP/p300 and HDAC1/2 15.77
Opposing Effects of Cyclooxygenase-2 (COX-2) on Estrogen Receptor β (ERβ) Response to 5α-reductase Inhibition in Prostate Epithelial Cells 15.53
Transcriptome analysis of dominant-negative Brd4 mutants identifies Brd4-specific target genes of BET inhibitor JQ1 15.24
Atheroprotective flow alters EZH2/H3K27me3 dependent transcriptional profile in human endothelial cells 15.18
Transcriptomes analysis for the regulation of Z36 induced autophagy in HeLa cell death 15.17
Oncogenic Notch promotes long-range regulatory interactions within hyperconnected 3D cliques [HCC1599_RNA-seq] 15.13
N6-methyladenosine mRNA marking promotes selective translation of regulons required for human erythropoiesis[Ribosome Profiling] 15.04
RNAseq Study in CC-671 Treated Cal-51 Cells 15.0
A novel lncRNA lncRNA-AK096729 promotes colorectal carcinogenesis and glucose metabolism by stabilizing and specifying the transcription modification pattern of c-Myc 14.96
In vitro differentiation of human low threshold mechanoreceptive (LTMR) neurons from embryonic stem cells 14.93
Ribosomal footprinting of MDA-Parental and MDA-LM2 14.92
Comparison of expression profiles of APP-depleted prostate cancer cells (LNCaP) 14.78
Nrf2 regulated genes in A549 cells 14.74
Identification of Nrf2 regulated genes by RNA sequencing 14.74
MeRIP sequencing reveals angiogenic properties of vascular endothelial cells 14.74
An RNA-centric dissection of host complexes controlling flavivirus infection 14.7
An RNA-centric dissection of host complexes controlling flavivirus infection [RNA-Seq] 14.7
Human cell line and subcutaneous tumor 14.63
Osteogenic programming of adipose-derived mesenchymal stem cells using a fungal metabolite that suppresses the Polycomb protein EZH2 14.33
AZ1366: An inhibitor of tankyrase and the canonical Wnt pathway that limits the persistence of non-small cell lung cancer cells following EGFR inhibition 14.3
Targeting the androgen receptor N-terminus via the cochaperone Bag-1L [RNA-Seq KO] 14.28
Lyophilized human cells stored at room temperature preserve multiple RNA species at excellent quality for RNA sequencing 14.25
Reprogramming of human stem cells towards a rejuvenated and transformation-resisting state by recoding a single nucleotide 14.11
Estrogen deprivation triggers and immunosuppressive phenotype in breast cancer cells 14.04
Ribosomal footprinting of MDA_Ctrl and MDA_Arg overexpression cell lines 14.03
Cleavage Factor Im as a key regulator of 3’ UTR length 13.97
Whole-Transcriptome Profiling of Canine and Human in Vitro Models Exposed to a G-Quadruplex Binding Small Molecule 13.95
Novel mutations segregating with Complete Androgen Insensitivity Syndrome and their molecular characteristics. 13.94
Next Generation Sequencing Facilitates Quantitative Analysis of HIV-1 Latency in Central Memory T Cells 13.93
3’ Uridylation Expands miRNA Target Repertoire 13.77
Benzotriazoles reactivate latent HIV-1 through inactivation of STAT5 SUMOylation (RNA-Seq) 13.76
Benzotriazoles reactivate latent HIV-1 through inactivation of STAT5 SUMOylation 13.76
Novel Form of JARID2 is Required to Regulate Differentiation in Keratinocytes. 13.68
Trisomy of a ‘Down syndrome critical region’ globally amplifies transcription via HMGN1 overexpression 13.67
The regulartory role of ZCCHC24 in splicing machinery 13.66
The mechanism of HHT in treating acute myeloid leukemia on RNA level. 13.62
Transcriptomic analysis of effect of oncolytic measles virus (MV) on transformed and non-transformed bone marrow-derived mesenchymal stem cells (MSCs) 13.6
Complementary Post Transcriptional Regulatory Information is Detected by PUNCH-P and Ribosome Profiling 13.53
Culture-induced recurrent epigenetic aberrations in human pluripotent stem cells 13.4
Culture-induced recurrent epigenetic aberrations in human pluripotent stem cells [RNA-seq] 13.4
Differetially expressed genes after hTR overexpression in U2OS cells 13.23
Lipid catabolism inhibition sensitizes prostate cancer cells to antiandrogen blockade 13.22
Oxaliplatin resistance is enhanced by saracatinib via upregulation of ABCG1 and Wnt/β-catenin signaling in hepatocellular carcinoma 13.18
Inhibition of SF3B1 by molecules targeting the spliceosome in Rh18 cells 13.11
Cooperation of GRSF1 and the mitochondrial degradosome (hSuv3-PNPase complex) in degradation of mitochondrial RNA 13.1
A transcriptome dataset revealing the molecular features of breast cancer stem cells 13.08
Transcriptomic Reprogramming of Prostate Cancer Cells Driven by Stroma-Derived AREG 13.0
A Brain Penetrant Mutant IDH1 Inhibitor Provides In Vivo Survival Benefit 12.98
Transcriptome Sequencing of Adipose-Derived Mesechymal Stromal Cells 12.96
Pharmacologic inhibition of STAT5 in AML 12.95
Determination of tRNA aminoacylation levels by high throughput sequencing 12.92
Single-cell transcriptomics of the human placenta: inferring the cell communication network of the maternal-fetal interface 12.89
Modulation of gene transcription and epigenetics of colon carcinoma cells by bacterial membrane vesicles 12.88
Combinatorial Reprogramming of Estrogen Signaling by the Nuclear Receptor Family 3C 12.88
Divergent effects of eRF3 and Upf1 on the expression of uORF carrying mRNAs and ribosome protein genes 12.81
Targeting Glioblastoma Stem Cells through Disruption of the Circadian Clock [RNA-Seq] 12.75
Targeting Glioblastoma Stem Cells through Disruption of the Circadian Clock 12.75
Triplet nucleotide repeat-based siRNAs are highly toxic to cancer cells 12.72
Differentially expressed vascular development genes for iPSC-ECs from CDI 12.68
Dtx3L and Androgen Signaling in Prostate Cancer 12.61
DHX9 suppresses spurious RNA processing defects originating from the Alu invasion of the human genome [uvCLAP CLIP-seq] 12.47
Evolved Labels of Placental Invasion in Human and Bovine Endometrial Stroma 12.41
miRNA-1343 attenuates pathways of fibrosis by targeting the TGF-beta receptors [RNA-seq] 12.35
Differential gene expression tools exhibit substandard performance for long non-coding RNA-sequencing data 12.21
The histone H3.3K36M mutation reprograms the epigenome of chondroblastomas 12.14
RNAseq of PRMT4KD in human cord blood derived CD34+ cells 12.1
Transcriptome analysis reveals malignant and hypoxic signature of glioblastoma 12.07
Quantitative Analysis of negative control and overexpression-TRIB1 in PC3 and DU145 Transcriptomes 12.07
SMYD2 specificly regulate BIX-01294 induced TP53 target genes revealed by RNA-Seq 12.05
Polycomb- and Methylation-Independent Roles of EZH2 as a Transcription Activator 11.91
Polycomb- and Methylation-Independent Roles of EZH2 as a Transcription Activator [RNA-seq] 11.91
Proteasome machinery is instrumental in a common gain-of-function program of the p53 missense mutants in cancer. 11.83
Proteasome machinery is instrumental in a common gain-of-function program of the p53 missense mutants in cancer. 11.83
TRPS1 shapes YAP/TEAD-dependent transcription in breast cancer cells 11.82
TRPS1 shapes YAP/TEAD-dependent transcription in breast cancer cells [RNA-seq] 11.82
Vitamin d receptor-mediated stromal reprogramming suppresses pancreatitis and enhances pancreatic cancer therapy 11.77
The MLL-AF9 and MLL-AF4 oncofusion proteins bind a distinct enhancer repertoire and target the RUNX1 program in MLLr AML 11.74
Downregulation of DDX5/DDX17 and REST 11.71
SMN2 splicing modifiers improve motor function and longevity in mice with spinal muscular atrophy 11.7
CDK12 catalytic activity is rate-limiting for RNAPII processivity on core DNA replication genes and G1/S progression 11.66
The ALK downregulated target gene HBP1 and repressor of MYCN activity as synergistic target for combined PI3K/HDAC inhibition [RNA-Seq] 11.65
The ALK downregulated target gene HBP1 and repressor of MYCN activity as synergistic target for combined PI3K/HDAC inhibition 11.65
Impact of GDF15 expression of ovarian cancer cell on stroma and Cisplatin responses 11.62
Cellular gene expression during Hepatitis C Virus replication revealed by Ribosome profiling 11.61
Transcriptional responses of human insulinoma cells to acute cytokine exposure 11.58
Modeling the MYC-driven normal-to-tumour switch in breast cancer. 11.51
Neurotrophic Tyrosine Kinase Receptor 1 is Epigenetically Regulated by IL-13 and Contributes to Allergic Inflammation 11.51
Poly(A)-specific ribonuclease (PARN) mediates 3' end maturation of the telomerase RNA component 11.29
Differential gene expression analysis between proliferating and quiescent human dermal fibroblasts 11.28
Adenovirus Small E1A Employs the Lysine Acetylases p300/CBP and Tumor Suppressor Rb to Repress Select Host Genes and Promote Productive Virus Infection 11.23
Adenovirus Small E1A Employs the Lysine Acetylases p300/CBP and Tumor Suppressor Rb to Repress Select Host Genes and Promote Productive Virus Infection [RNA-seq] 11.23
Identifying lincRNA as prognostic biomarker for clear cell renal cell carcinoma 11.17
Che-1 is targeted by c-Myc to sustain proliferation in pre-B-cell acute lymphoblastic leukemia 11.17
Che-1 is targeted by c-Myc to sustain proliferation in pre-B-cell acute lymphoblastic leukemia [RNA-seq] 11.17
MDM2 and MDM4 are Therapeutic Vulnerabilities in Malignant Rhabdoid Tumors 11.16
Single-cell transcription profiling in KS1 patient iPSCs and NPCs 11.16
Transcriptional alteration after ionizing radiation exposure in human fibroblasts, iPSCs and NPCs 11.13
BET bromodomain proteins function as master transcription elongation factors independent of CDK9 recruitment [NET-seq] 11.06
MKL1 augments megakaryocyte maturation by enhancing the SRF regulatory axis 11.04
MKL1 augments megakaryocyte maturation by enhancing the SRF regulatory axis [RNA-seq] 11.04
Expression profile of LNCaP/AR cells with or without HNF4G expression grown for long term in charcoal stripped-serum (CSS) media 11.01
Whole transcriptome RNA sequencing of human cells after HCV infection (ML-1 thyroid cell line, primary thyrocytes and Huh7.5 hepatocyte cell line) 10.99
Gene expression analysis of C4-2 cells treated with ACLY inhibitor and Enzalutamide 10.97
Epigenetic Therapy Increases Therapeutic Efficacy in Myeloproliferative Neoplasms Through Inhibition of Aberrant Inflammatory Signaling 10.96
Nuclear Actin Regulates Inducible Transcription by Enhancing RNA Polymerase II Clustering 10.85
Analysis of regulatory element evolution between human and mouse reveals a lack of cis-trans compensation 10.84
RNA-Seq profiling in PBMCs and spinal cord from ALS patients and healthy controls 10.82
Comprehensive RNA-Seq profiling in PBMCs of ALS patients and healthy controls 10.82
Neurofibroma 10.81
Differential expression in wild-type and mutant neurofibroma and MPNST cell lines 10.81
Gene expression data from IMR90 control, IMR90 shRRM2 and shRRM2/shp16 10.79
STVI-120 Induction of differentiation in human epidermal stem cells followed by differential splicing analysis 10.7
Whole-transcriptome profilings between a pair of HCA7-derived KRAS-wildtype cetuximab sensitive and resistant colon cancer cells from 3D culture 10.64
UBL5 is essential for pre-mRNA splicing and sister chromatid cohesion in human cells 10.56
LINE-1 elements are derepressed in senescent cells and elicit a chronic Type-I Interferon response 10.56
Long non-coding RNA SMILR regulates genes involved in cytokinesis in human vascular smooth muscle cell 10.55
Lineage tracing of acute myeloid leukemia reveals the impact of hypomethylating agents on chemoresistance selection 10.55
RNA-seq transcriptonal profiling in human primary adult erythroid progenitor cells (ProEs) after shRNA-mediated depletion of TFAM and PHB2 expression 10.53
Identification of genes regulated by Long noncoding RNA H19 in hepatic cells 10.51
H19 regulates hepatic glucose production by epigenetic modification of Hnf4* 10.51
Mining the stiffness-sensitive transcriptome in human vascular smooth muscle cells identifies long non-coding RNA stiffness regulators 10.5
Gene expression profile of LMSU gastric cancer cell p53 KO and KD 10.47
Axitinib exposure triggers endothelial cells senescence through ROS accumulation and ATM activation 10.41
RUNX1-ETO and RUNX1-EVI-1 differentially program the chromatin landscape in t(3;21) and t(8;21) AML but share global C/EBP-alpha dysfunction (RNA-Seq) 10.38
RUNX1-ETO and RUNX1-EVI-1 differentially program the chromatin landscape in t(3;21) and t(8;21) AML but share global C/EBP-alpha dysfunction 10.38
The SUMO Pathway as a Therapeutic Option in Pancreatic Cancer 10.34
Adaptive chromatin remodeling in glioblastoma stem cell plasticity and drug tolerance 10.31
LINC00520 is Induced by Src, STAT3, and PI3K and Plays a Functional Role in Breast Cancer 10.3
Base-resolution mapping reveals distinct classes of N1-methyladenosine methylome in nuclear- and mitochondrial-encoded transcripts 10.27
Global modulation of signaling pathways by SARM RAD140 in AR/ER+ breast cancer xenografts 10.22
Global Transcriptome Analyses of Mammalian Terminal Erythroid Differentiation 10.21
Transcriptome profile of HepG2-expressing ATP7B-H1069Q (liver hepatocellular cells) exposed to JNK or p38 Inhibitor 10.19
Comprehensive comparative analysis of RNA sequencing methods for degraded or low input samples 10.19
Control of human hemoglobin switching by LIN28B-mediated regulation of BCL11A translation 10.19
Inhibition of DNA methylation promotes breast tumor sensitivity to netrin-1 interference [RNA-Seq] 10.17
Inhibition of DNA methylation promotes breast tumor sensitivity to netrin-1 interference 10.17
Transcriptomes change differerntly in differernt cancer cells upon EPZ-6438 treatment 10.14
Transcriptomic analysis of the HOTAIR-regulated genes 10.14
ATF4 inhibition by p62 represses stromal metabolic reprogramming and tumorigenesis II 10.13
Alternative splicing of differentiated myeloid cell transcripts after infection by Anaplasma phagocytophilum impacts a selective group of cellular programs 10.08
Disease Model of GATA4 Mutation Reveals Transcription Factor Cooperativity in Human Cardiogenesis [RNA-Seq] 10.08
Disease Model of GATA4 Mutation Reveals Transcription Factor Cooperativity in Human Cardiogenesis 10.08
Chemotherapeutic drugs inhibiting Topoisomerase 1 activity inhibit TNF-induced inflammatory gene expression 10.01
RNA-seq analysis of differentiating human erythroblasts 10.0
Epigenome-wide Effects of Vitamin-D on Bronchial Epithelial Cells using ATAC-Seq and RNA-seq 9.95
A code of mono-phosphorylation modulates the function of RB. 9.94
Catalogue of differentially expressed long non-coding RNAs following activation of human and mouse innate immunity 9.93
Extracellular matrix hydrogel derived from decellularized tissues enables endoderm organoids culture 9.93
Global analysis of alternative splicing regulated by RBM10 9.91
CHD7 is Suppressed in the Perinecrotic/Ischemic Microenvironment and is a Novel Regulator of Angiogenesis 9.89
RNA-sequencing of human mammary epithelial cells (HMLEs) transduced in vitro with a shRNA against SOX4 or a scrambled shRNA in untreated and TGF-β-treated (16 hours) conditions 9.89
Comparative transcriptomic analysis of human and Drosophila extracellular vesicles reveals extensive conservation 9.88
Genome models integrating chromatin contacts and nuclear lamin-genome interactions reveal implications of laminopathy-causing lamin mutations on genome architecture 9.82
RING-finger protein 6 amplification activates JAK/STAT3 pathway by modifying SHP-1 ubiquitylation and associates with poor outcome in colorectal cancer 9.8
Transcription control by the ENL YEATS domain in acute leukemia 9.79
Transcription control by the ENL YEATS domain in acute leukemia [RNA-seq] 9.79
The Molecular Dissection of the Oncogenic Role of ETS1 in the Mesenchymal Subtypes of Head and Neck Squamous Cell Carcinoma [RNA-seq knock-down] 9.78
Transcriptome analysis of Zika infected neural stem cells 9.75
Zika infected neural stem cells 9.75
EIF1AX-A113 splice and RAS mutations cooperate to drive thyroid tumorigenesis through ATF4 and c-MYC 9.73
A novel Menin-MLL inhibitor induces specific chromatin changes and eradicates disease in models of MLL-rearranged leukemia [RNA-Seq II] 9.7
Trans-differentiation of human adult peripheral blood T cells into neurons 9.66
Sensing self and nonself circular RNAs 9.63
Patient-iPSC-derived kidney organoids show functional validation of a ciliopathic renal phenotype 9.62
The LIN28B/let-7 axis is a novel therapeutic pathway in Multiple Myeloma 9.61
Isolation and Transcriptome Analyses of Human Erythroid Progenitors: BFU-E and CFU-E 9.6
RNA-seq analysis reveals profound changes in transcript profiles between siCon- and siH19-transfected EVT cells 9.59
Implication of Long noncoding RNAs in the endothelial cell response to hypoxia revealed by RNA-sequencing. 9.57
BRG1 recruitment by transcription factors MITF and SOX10 defines a specific configuration of regulatory elements in the melanocyte lineage (RNA-seq) 9.54
BRG1 recruitment by transcription factors MITF and SOX10 defines a specific configuration of regulatory elements in the melanocyte lineage 9.54
H3K27Ac in MCF7 Y537S ER mutant cells and RNAseq with and without treatment with THZ1 9.51
A Werner syndrome stem cell model unveils heterochromatin alterations as a driver of human aging 9.5
RNA seq_A375 gSMARCB1 + A549 etoposide, Aurora kinases inhibitors treated 9.47
Global gene expression profile of dasatinib-resistant RCH-ACV cells 9.44
Changes in chromatin accessibility and gene expression induced by overexpression of ONECUT transcription factors 9.42
Profiling of gene expression using RNA-Seq in fibroblasts, iPSCs, iPSC-derived neurons and cells overexpressing Onecut transcription factors 9.42
The effect of very-high-molecular-mass hyaluronan (vHMM-HA) on IMR90 transcriptome 9.36
TNF response in promyelocytic and granulocytic forms of HL60/S4 cells 9.35
MYC dependent mRNA translation shapes gene expression and cell biology 9.32
Genome-wide view of the impact of Spt5-Pol II inhibitors (SPIs) on mRNA levels [RNA-Seq 24h] 9.32
Retinoic Acid Induced Transcriptional Repressor HIC1 is Required for Suppressive Function of Human Induced Regulatory T cells [RNA-Seq 1] 9.3
Comparative principles of DNA methylation reprogramming during human and mouse in vitro primordial germ cell specification 9.29
Comparative principles of DNA methylation reprogramming during human and mouse in vitro primordial germ cell specification [Mouse and Human RNA-seq and BS-seq] 9.29
Transcriptome analysis of A549 cells expressing a SUMOylation-deficient TRIM28 mutant in the context of influenza A virus infection 9.28
High-throughput sequencing of PROMPT-enriched samples. 9.2
Inherent DNA binding specificities of the HIF-1α and HIF-2α transcription factors in chromatin (RNA-seq) 9.19
Inherent DNA binding specificities of the HIF-1α and HIF-2α transcription factors in chromatin 9.19
Distinct changes in transcriptional profiles and epigenetic patterns mediated by EZH2 inhibitors in sensitive and insensitive prostate cancer cells 9.19
EZH2 inhibitor-mediated transcriptional profiling in prostate cancer cells [RNA-seq] 9.19
Comprehensive evaluation of differential gene expression analysis methods for RNA-seq data 9.16
Pluripotent stem cell model of Nakajo-Nishimura syndrome untangles proinflammatory pathways mediated by oxidative stress 9.16
Apatinib preferentially inhibits Gefitinib-resistant lung cancer cells by inducing cell cycle arrest and inhibiting VEGFR signaling pathway 9.15
Differential expression of pancreatic cancer PANC1 cells treated with pilocarpine 9.14
circ-ZNF609 regulates G1-S progression in Rhabdomyosarcoma 9.07
Comparing effects of perfusion and hydrostatic pressure on human chondrocytes using gene profiles 9.04
RNA-sequencing of isogenic primary, pre-malignant immortalized, and Ras-transformed human mammary epithelial cells 9.03
Ex-vivo Human Hematopoietic Stem Cell Expansion Requires Coordination of Cellular Reprogramming with Mitochondrial Remodeling and P53 Activation 9.02
Global analysis of ZNF217 chromatin occupancy in the breast cancer cell genome reveals an association with Eralpha 8.98
Nudt3 is a mRNA Decapping Enzyme That Modulates Cell Migration 8.95
Disruption of the exocyst induces podocyte loss and dysfunction 8.94
Convergent roles of ATF3 and CSL in chromatin control of CAF activation [RNA-seq] 8.93
Convergent roles of ATF3 and CSL in chromatin control of CAF activation 8.93
Innate-like activation of mucosal-associated invariant T cells in mycobacterial infection 8.89
Expression and functions of long noncoding RNAs during human T helper cell differentiation 8.88
Transcriptomic but not genomic variability confers phenotype of breast cancer stem cells 8.86
Fbxo32 mediated gene expression program underlies EMT and metastasis 8.86
Effects of Polybrominated Diphenyl Ether (PBDE) Mixture on estrogen receptor positive (ER+) patient-derived tumor xenograft (PDX) model 8.86
Next generation sequencing analysis of transcriptomes at different timepoints after chlorprothixene treatment in NB4 and Kasumi-1 cells 8.85
The translation termination factor GSPT1 is a phenotypically relevant off-target of heterobifunctional phthalimide degraders 8.81
Assessing the effect of SUPT4H1 RNAi on the transcription of a repeat-containing reporter construct 8.79
Global Mapping of Human RNA-RNA Interactions 8.76
A Hybrid Mechanism of Action for BCL6 in B Cells Defined by Formation of Functionally Distinct Complexes at Enhancers and Promoters 8.76
Transcriptomic analyssis following EHMT1/2 inhibition 8.74
MUC1-C represses the RASSF1A tumor suppressor and activated Kras signaling in human carcinoma cells 8.71
Cerebellar differentiation in Ataxia-Telangiectasia 8.66
Distinct Roles of BET Family Members in ERα Enhancer Function and Gene Regulation in Breast Cancer Cells 8.66
Distinct Roles of BET Family Members in ERα Enhancer Function and Gene Regulation in Breast Cancer Cells [RNA-seq] 8.66
ATRX is necessary for cellular senescence and represses HRAS to drive cells from quiescence into senescence 8.64
ATRX is necessary for cellular senescence and represses HRAS to drive cells from quiescence into senescence [RNA-Seq] 8.64
CREB5 promotes resistance to androgen-receptor antagonists and androgen deprivation in prostate cancer 8.64
Global transcriptional changes in U87MG glioblastoma cells upon shRNA-mediated TRIM52 knockdown 8.63
RNA sequencing of matched nephrectomy samples [RNA-seq] 8.61
Genome-wide maps of H3K36me3 in ccRCC and RNA-seq of matched nephrectomy samples 8.61
Montelukast counteracts the influenza virus-induced block in unfolded protein stress response and reduces virus multiplication 8.6
Differentially expressed (DE) genes analysis in synovial fluid mesenchymal stem cells (SF-MSCs), SF-MSC derived iPSCs and iPSC derived MSCs (iPSC-MSCs) 8.59
Single-cell RNA sequencing-based CRISPRi screening resolves molecular drivers of early human endoderm development 8.57
Recovery and analysis of nascent RNA 8.44
The oncogenic BRD4-NUT chromatin regulator drives aberrant transcription within large topological domains 8.44
An atlas of TNF-α-responsive promoters and enhancers in the intestinal epithelial cell model Caco-2 8.44
shRNA knockdown of YAP1 in HCC364 cells, various drug conditions 8.42
The metabolome regulates the epigenetic landscape during naïve to primed human embryonic stem cell transition 8.41
Triple vectors expand AAV transfer capacity in the retina 8.4
Modeling and characterization of the dynamic gene regulatory networks underlying cancer drug resistance based on time-course RNA-seq data 8.4
Genome-wide CRISPR-Cas9 screen identifies functionally relevant microRNAs in AML 8.37
Expression profile of wild type (WT) vs miR-155-/- in FLT3-ITD+ AML (MV4-11) cell lines 8.37
Global analyses of the effect of different cellular contexts on microRNA targeting (RNA-Seq) 8.37
Global analyses of the effect of different cellular contexts on microRNA targeting 8.37
Toxoplasma gondii remodels the cis-regulatory landscape of infected human host cells [RNA-seq] 8.36
Toxoplasma gondii remodels the cis-regulatory landscape of infected human host cells 8.36
An aspartyl protease defines a novel pathway for export of Toxoplasma proteins into the host cell 8.34
A global identification of PUM1 and PUM2 mRNA targets and their protein cofactors in human seminoma TCam-2 cells 8.32
Identification of HOXB13 target genes responsive to BET inhibitors 8.28
Comparative whole-transcriptomic analysis between normal and AKAP-Lbc-depleted human embryonic stem cells 8.25
RNA-seq of resting and activated CD4+ T cells +-JQ1 8.23
Transcriptomic analysis of healthy donor and Sickle Cell Disease (SCD) hematopoietic stem/progenitor cells 8.18
Expression data from A2780 cells treated with DMSO, Olaparib(Ola), Palbociclib(PD), and their combination (Ola/PD) 8.15
High-efficiency RNA-based reprogramming of human primary fibroblasts 8.14
Efficient and quantitative high-throughput tRNA sequencing 8.14
Identification of Sin3B regulated genes during quiescence 8.1
High throughput analysis of three human adipose cell lines PAZ6, SGBS and SW872 8.09
The impact of pro-inflammatory cytokines on the β-cell regulatory landscape provides insights into the genetics of type 1 diabetes 8.09
RNA-sequencing in irradiated and normal A549 cells. 8.09
A quantitative chemotherapy genetic interaction map identifies new factors associated with PARP inhibitor resistance 8.05
Essential Roles of SETD7 as Transcriptional Activator and Co-regulator of H3K36me in Cardiac Lineage Commitment 8.03
RNA-seq data corresponding to: AZD4573 is a highly selective CDK9 inhibitor that suppresses Mcl-1 and induces apoptosis in hematological cancer cells 8.02
CHD1 loss sensitizes prostate cancer to DNA damaging therapy by promoting error-prone double-strand break repair 7.99
Profiling of escape kinetics of viruses subjected to RNAi 7.97
ATXN7L3 And ENY2 Coordinate Activity Of Multiple H2B Deubiquitinases Important For Cellular Proliferation And Tumor Growth [RNA-Seq] 7.95
ATXN7L3 And ENY2 Coordinate Activity Of Multiple H2B Deubiquitinases Important For Cellular Proliferation And Tumor Growth 7.95
Gene expression changes upon drug withdrawal (A375/451Lu cell lines) 7.95
Polysome profiling RNAseq of cells transfected with an oligonucleotide targeting the ES6S region of the 40S subunit 7.88
High-throughput RNA sequencing on circular RNA profiles of human pancreatic cancer cell lines and gemcitabine resistant pancreatic cancer cell lines. 7.85
Gene expression profiling of LNCaP cells following shRNA-mediated knockdown of TMEFF2 and growth in presence and absence of dihydrotestosterone 7.85
CENPA-Bound Genes and Transcriptional Profiling of CENPA-Depleted Prostate Cancer Cells 7.83
Transcriptional Profiling of CENPA-Depleted Prostate Cancer Cell Lines 7.83
Genome-scale identification of transcription factors that mediate an inflammatory network during breast cellular transformation 7.81
RNA-seq during MCF10A-ER-Src cell transformation and upon factor knockdowns 7.81
Genes significantly down or Up-regulated upon RNF219 knockdown. [RNA-Seq] 7.8
SIRT7 Antagonizes TGF-β Signaling and Inhibits Breast Cancer Metastasis 7.8
HuR controls apoptosis and activation response without effects on cytokine 3′ UTRs 7.78
RNA-sequencing of human mammary epithelial cells (HMLEs) engineered to express either ER or ER-SOX4 with and without 4-OHT to induce nuclear translocation 7.75
Targeting MYC dependency in ovarian cancer through inhibition of CDK7 and CDK12/13 7.73
Splicing and epigenetic factors jointly regulate epidermal differentiation 7.66
CXCR4 is a host factor that regulates Plasmodium development in hepatocytes 7.65
A map of gene expression in neutrophil-like cell lines 7.64
tRNA modification landscape selectively controls mitochondrial translation efficiency in MERRF 7.62
Differential Protein Occupancy Profiling of the mRNA Transcriptome 7.6
Effect of CRISPR-Cas9 mediated knock-out of integrin alpha2 on the transcriptome of DU145 prostate cancer cell grown as a spheroid culture 7.58
The Genetic Landscape of Diamond-Blackfan Anemia 7.57
RNA-seq of human aneuploid cell lines with Trisomy 21 7.54
Bach1 Regulates the Self-renewal and Mesendodermal Differentiation of Human Embryonic Stem Cells 7.49
EWS-Fli and LNC regulated genes in comparison to GFP samples 7.46
Specific labeling of stem cell activity in human colorectal organoids using an ASCL2-responsive minigene 7.46
Analysis of transcriptional regulation by Myt1 and Myt1l 7.41
Messenger RNA expression after silencing or inhibition of MEN1in MCF-7 breast cancer cells 7.38
Human cells contain natural double-stranded RNAs with potential regulatory capacity 7.37
FGF2 induces migration of human bone marrow stromal cells by increasing core-fucosylations on N-glycans of integrins 7.37
The mRNA export receptor NXF1 coordinates transcriptional dynamics, alternative polyadenylation and mRNA export 7.32
Ribo_seq (aka ribosome profiling) analysis of control and Myc-induced U2OS cells 7.28
Systematic discovery of endogenous human ribonucleoprotein complexes 7.22
Transcriptome-wide identification of transient RNA G-quadruplexes in human cells 7.2
Transcriptome analysis of PRMT6 knock-out in NT2/D1 cells 7.16
Genomic location of PRMT6-dependent H3R2 methylation is decisive for the transcriptional outcome of associated genes 7.16
Gene-Edited Human Kidney Organoids Reveal Mechanisms of Disease in Podocyte Development 7.16
Transcriptional regulation of autophagy-lysosomal function in BRAF-driven melanoma progression and chemoresistance 7.13
Chronic cadmium exposure decreases the dependency of MCF7 breast cancer cells on ERα 7.13
Regulation of the glucocorticoid receptor via a BET-dependent enhancer drives antiandrogen resistance in prostate cancer 6.96
Ro60-knockout cells 6.9
Differential expression analysis of RNA-seq data from melanocytes driven by tumor cell-derived exosomes 6.83
Splicing towards noncoding isoforms in colorectal carcinoma is associated with tumor hypoxia and the DNA damage response 6.8
Genes directly regulated by NF-κB in human hepatocellular carcinoma HepG2 6.74
Genes directly regulated by NF-κB in human hepatocellular carcinoma HepG2 [RNA-seq] 6.74
RNA-seq reveals abundant circRNA, lncRNA and mRNA in blood exosomes of patients with pancreatic carcinoma 6.73
Distinct structural classes of activating FOXA1 alterations in prostate cancer progression [RNA-Seq] 6.65
Distinct structural classes of activating FOXA1 alterations in prostate cancer progression 6.65
Gene expression from AsPC-1 cells treated with PTC596 and DMSO 6.64
Molecular Criteria for Defining the Naive Human Pluripotent State 6.6
RNA transcriptome analysis during HSV-1 infection 6.59
Genome-wide analysis of Dengue virus 2 infected cells 6.51
RNA-sequencing transcriptome profiling of normal human keratinocytes differentiation 6.36
Overexpression of PHF8 promotes an EMT-related gene signature in MCF10A cells 6.2
Epigenetic profiling and RNA-sequencing of Juvenile Idiopathic Arthritits (JIA) patients 6.13
RNA-sequencing of cells derived from the site of inflammation of Juvenile Idiopathic Arthritis patients 6.13
The anti-leukemic effect of R-2HG depends on its acting as an m6A mRNA modifier-RNA Seq-Resistant, sensitive and healthy control 6.11
Widespread backtracking by RNA pol II is a major effector of gene activation, 5’ pause release, termination and transcription elongation rate 6.11
Nucleosome dynamics in human colorectal cancer specimens reveal activation of a CNOT3-regulated pathway of embryonic stem cell self-renewal 6.11
Oncogenic changes and EMT in normal human bile duct epithelial cells are caused by parasite-derived materials and N-nitrosodimethylamine 6.1
Identification of PAX7-induced transcriptional changes and PAX7 genomic binding during skeletal myogenic differentiation of H9 embryonic stem cells 6.07
RNA-seq of naive and primed ES cells 6.05
Non-transmissible measles virus vector with segmented RNA genome establishes different types of iPSCs from hematopoietic cells 6.05
Human iPSC-derived microglia assume a primary microglia-like state after transplantation into the neonatal mouse brain [Single Cell RNAseq] 6.03
Induction of human regulatory innate lymphoid cells from group 2 innate lymphoid cells by retinoic acid 5.94
Next Generation Sequencing Facilitates Quantitative Analysis of colorectal cancer cells transfected with NC siRNA or RPL9 siRNA 5.87
Prolyl Hydroxylase Substrate Adenylosuccinate Lyase Is An Oncogenic Driver In Triple Negative Breast Cancer 5.86
mTORC1 balances cellular amino acid supply with demand for protein synthesis through post-transcriptional control of ATF4 5.81
Transcriptome profiling of the interconnection of pathways involved in malignant transformation and response to hypoxia 5.73
lncRNA-PCAT1 knockdown effect on the gene expression of androgen independent LNCaP (LNCaP-AI) cell line 5.69
The p30 isoform of CEBPA uncovers a silent enhancer to drive the expression of the tumor promotive factor CD73 in CEBPA mutant AML 5.63
Poly(A)-ClickSeq resolves CF25-mediated alternative poly-adenylation, HeLa 5.6
Gene expression analysis of CD4+ and CD4- ILC1 subsets by RNAseq 5.59
Argonaute proteins couple chromatin silencing to alternative splicing 5.57
Argonaute proteins couple chromatin silencing to alternative splicing (RNA IP-Seq) 5.57
Transcriptomic analysis of acute mitochondrial pyruvate carrier inhibition using UK5099 in ABL prostate cancer cells 5.55
Role of BET proteins in YAP/TAZ-dependent transcription [RNA-seq 1] 5.41
RNA-seq of RKO cells with cTAZ KO or putback 5.27
INO80 governs super-enhancer-mediated oncogenic transcription and tumor growth in melanoma 5.21
INO80 governs super-enhancer-mediated oncogenic transcription and tumor growth in melanoma [RNA-seq] 5.21
LEDGF and HDGF2, histone H3K36 methyl-binding proteins that assist RNA polymerase II transcription through nucleosomes 4.98
Next Generation Sequencing Facilitates Quantitative Analysis of UVB(20mJ/cm2 and 40mJ/cm2) exposed and untreated HaCaT keratinocytes Transcriptomes 4.96
BRD9 defines a novel SWI/SNF sub-complex and constitutes a specific vulnerability in malignant rhabdoid tumors [RNA-seq 2] 4.96
RNA-seq analysis of human cardiosphere cells with different tubule supportive potential 4.89
Nuclear receptor RORγ is a targetable master regulator of cholesterol in a subtype of breast cancer 4.84
Role of SUMOylation in differential ERα transcriptional repression by SERMs and pure antiestrogens in breast cancer cells 4.82
mitoCPR - a surveillance pathway that protects mitochondria in response to mitochondrial import stress 4.81
mitoCPR - a surveillance pathway that protects mitochondria in response to mitochondrial import stress [human] 4.81
Cis-Regulatory Circuits Regulating NEK6 Kinase Overexpression in Transformed B Cells Are Super-Enhancer-Independent (RNA-seq) 4.8
Cis-Regulatory Circuits Regulating NEK6 Kinase Overexpression in Transformed B Cells Are Super-Enhancer-Independent 4.8
ETS1 acts as a tumor suppressor in breast cancer by inhibiting growth-related factors 4.63
In Vitro and In Vivo Modulation of Alternative Splicing by the Biguanide Metformin. 4.62
Activation of Wnt/beta-catenin in Ewing sarcoma cells antagonizes EWS/ETS function and promotes phenotypic transition to more metastatic cell states 4.55
Wnt5a and its downstream transcription factor Stat3 are therapeutic targets for diffuse intrinsic pontine gliomas 4.53
Exploring the gene expression profile upon FXR1 knockdown in H358 cells using RNA-seq 4.48
The cohesin release factor WAPL restricts chromatin loop extension. [RNA-Seq] 4.4
The cohesin release factor WAPL restricts chromatin loop extension. 4.4
Identification of miRNA signatures during the differentiation of hESCs into retinal pigment epithelial cells 4.36
HBEC-shp53-PCHD7 4.34
Organoids derived from directly reprogrammed human hepatocytes for modeling liver cancer initiation 4.31
Impact of library preparation on downstream analysis and interpretation of RNA-seq data: comparison between Illumina PolyA and NuGEN Ovation protocol 4.23
Identification of ADAR1 adenosine deaminase dependency in a subset of cancer cells 4.1
DHX36 resolves G-rich structures in mRNA untranslated region to allow their translation 4.08
TrapSeq: An RNA Sequencing-based pipeline for the identification of genetrap insertions in mammalian cells 3.99
Conservative alteration of chromosomal expression pattern across human solid tumor types 3.95
Rapid neurogenesis through transcriptional activation in human stem cell (RNA-Seq) 3.94
Characterization of Type I Interferon pathway during Hepatic Differentiation of Human Pluripotent Stem Cells and hepatitis C virus infection 3.92
METTL3 and WTAP 3.89
Multiplexed engineering and analysis of endogenous enhancer activity in single cells: Mosaic-Seq of beta-globin locus (pooled infection) 3.85
Gene expression profiling of human iPS cell-derived podocytes and sorted human adult podocytes 3.83
RNA:DNA hybrids in the human genome have distinctive nucleotide characteristics, chromatin composition, and transcriptional relationships (RNA-seq) 3.81
RNA:DNA hybrids in the human genome have distinctive nucleotide characteristics, chromatin composition, and transcriptional relationships 3.81
The DPYSL2 gene connects mTOR and schizophrenia 3.78
SMAD2/3 are redirected to novel sites in MCF10A MII after prolonged TGFβ stimulation 3.7
JUNB is a critical AP1 component for SMAD2/3 binding after TGFβ stimulation [RNA-seq] 3.7
Human Tfh cell RNA bulk sequencing 3.69
Effect of BCL11B knockdown on transcriptome of human T-cell precursors 3.67
Transcriptomic analysis of differential expressed genes of human tonsillar epithelial cells UT-SCC-60B in response to EV71 infection 3.55
Next Generation Sequencing (RNA-Sequencing) for the analysis of RUNX3 targets in H460, H460-ERT2-RUNX3 WT and H460-ERT2-RUNX3 MT(K94/171R mutation) 3.54
Poly(ADP-ribose) polymerase 1 is necessary for coactivating hypoxia-inducible factor-1-dependent gene expression by Epstein-Barr virus latent membrane protein 1 3.42
Transient stabilization, rather than inhibition of MYC amplifies extrinsic apoptosis and therapeutic responses in refractory B-cell lymphoma 3.39
Transcriptome profiling (RNA-seq) of CREBBP+/+ and CREBBP+/- clones of U2932 DLBCL cell line 3.38
RNA deep sequencing to compare genome-wide differences between PRMT5/knockdown and control AML cells 3.35
Circular RNA expression signature of low-glucose-treated MIA PaCa-2 cells 3.1
Fra-1 is a key driver of colon cancer metastasis and a Fra-1 classifier predicts disease-free survival 2.91
Small-molecule targeting of brachyury transcription factor addiction in chordoma [rnaseq_compound] 2.9
Identification of renal resident macrophages across species [C1] 2.84
Combined MEKi (GDC-0973) and WNT (G007-LK) treatment in APC and KRAS mutant HCT-15 cell line 2.8
A single-cell transcriptome atlas of the human pancreas 2.73
Spatially Constrained Tandem Bromodomain Inhibition Bolsters Sustained Repression of BRD4 Transcriptional Activity for TNBC Cell Growth 2.72
Modeling genome-wide transcriptional cis-regulation in n LNCaP-abl cell line after siRNA knock down of a series of gene factors [RNA-seq] 2.6
RNA-seq after siRNA targeting DDX24 applied to iHUVECs cell lines 2.48
RNA sequencing of isogenic BRCA2 haploinsufficient vs. wild-type T-ALL cells 2.46
Effect of Polybrominated diphenyl ethers (PBDEs) on gene expression of MCF7 cells 2.37
Chemical Enhancement of Direct Cardiac Reprogramming In Vitro and In Vivo 2.2
Programmable RNA N6-methyladenosine editing by CRISPR-Cas9 conjugates 2.15
Epigenome Editing by a CRISPR/Cas9-Based Acetyltransferase Activates Genes from Promoters and Enhancers 1.99
Differential mRNA expression upon 9p21 deletion in HEK TE single-cell derived clones 1.98
Loss of 9p21 regulatory hub promotes kidney cancer progression by upregulating HOXB13 1.98
DAOY-Notch1/Notch2 knockout: transcriptome comparison 1.85
Microprocessor mediates transcription termination in long noncoding microRNA genes 1.82
m6A level and isoform characterization sequencing (m6A-LAIC-seq) reveal the census and complexity of the m6A epitranscriptome 1.8
Gene expression profiles in HMC3 cells after exposure to ketamine or its active metabolites: 2R6R-HNK and 2S6S-HNK 1.79
RNA-Seq analysis of human colorectal cancer with liver metastasis 1.78
RNA-Seq of PRMT1 overexpression ECA109 cells 1.53
Measuring the effect of MYC on transcription during the DNA double-strand break response by RNA-seq of newly synthesized transcripts 1.52
Pro-angiogenic Ginsenoside F1 and Rh1 Inhibit Vascular Leakage by Modulating NR4A1 1.49
MicroRNA-28 replacement for non-Hodgkin lymphoma therapy 1.48
Gene expression profiling of neural crest progenitor cultures derived from human embryonic stem cells carrying nonsense mutations in the Polycomb gene ASXL1 1.43
Dynamic gene regulatory networks of human myeloid differentiation [RNA-seq_siRNA] 1.36
Effect of venetoclax, tedizolid, and combination treatment on gene expression in a venetoclax-resistant AML cell line 1.29
miR-126 Orchestrates an Oncogenic Program in B-Cell Precursor Acute Lymphoblastic Leukemia 1.21
The secretome of skin cancer cells activates the mTOR/MYC pathway in healthy keratinocytes and converts them into tumorigenic cells 1.14
Postmortem Cortex Samples Identify Distinct Molecular Subtypes of ALS: Retrotransposon Activation, Oxidative Stress, and Activated Glia [shRNA] 1.05
6mer seed toxicity in viral microRNAs 1.03
HMGA2 Promotes Long-Term Engraftment and Myelo-Erythroid Differentiation of Human Hematopoietic Stem and Progenitor Cells 0.95
The NFkB subunit RELA is a master transcriptional regulator of the committed epithelial-mesenchymal transition in airway epithelial cells 0.88
CDK12 mediated transcriptional regulation in U2OS cells 0.84
Analysis of gene expression in primary human foreskin keratinocytes +/- HPV16 E7 or PTPN14 knockout 0.81
Modulation of nonsense-mediated decay by rapamycin 0.76
Evaluation of the effectiveness of semen collection and sperm purification methods for spermatozoa transcript profiling 0.69
Class I histone deacetylases HDAC1, 2 and 3 are histone decrotonylases 0.69
Transcriptomics analysis of gene expression in normal and YTHDC1, SRSF1, SRSF3, SRSF7, SRSF9 or SRSF10 deficient human HeLa cells 0.68
Transcriptomic Alterations in Lung Adenocarcinoma Unveil New Mechanisms Targeted by the TBX2 Subfamily of Tumor Suppressor Genes 0.68
Interphase condensins regulate ligand-depedent enhancer activation (GRO-seq) 0.62
Interphase condensins regulate ligand-depedent enhancer activation 0.62
A cell cycle-based functional screen to identify lncRNA-based cancer biomarkers 0.56
WNT signaling memory is required for ACTIVIN to function as a morphogen 0.49
O-GlcNAc transferase fine-tunes MYC-dependent transcription to promote cell cycle [RNA-seq] 0.48
O-GlcNAc transferase fine-tunes MYC-dependent transcription to promote cell cycle 0.48
RNA-Seq of SHEP TET21N cells upon Doxorubicin treatment 0.46
DHX36 is the missing link to understand RNA G-quadruplex structures, mRNA stability, and translation [RNA-seq] 0.46
RNASeq of Arg2 gRNA or scrambled gRNA CRISPR'd Tregs 0.35
Transcriptomic profiling of sequential tumours from breast cancer patients provides a global view of metastatic expression changes following endocrine therapy 0.35
Drug combination of 17-AAG and Belinostat on MDA-MB-231 breast cancer cells 0.34
The novel lncRNA lnc-NR2F1 is pro-neurogenic and mutated in human neurodevelopmental disorders [lnc-Nr2f1 overexpression] 0.31
The novel lncRNA lnc-NR2F1 is pro-neurogenic and mutated in human neurodevelopmental disorders 0.31
HSB-2 cells stably expressing LDB1 or mutant LDB1 proteins 0.28
The multiple myeloma risk allele at 5q15 lowers ELL2 expression and increases ribosomal gene expression [ELL2 rescue] 0.25
KDM1A confers invasive and metastatic attributes in lung adenocarcinoma by modulating a non-canonical Integrin ß3-KRAS signaling pathway 0.23
Distinct and shared functions of ALS-associated TDP-43, FUS, and TAF15 revealed by comprehensive multi-system integrative analyses [RNA-Seq_Stability] 0.19
Transcriptional profiling of growing and senescent WT and IL-1R-depleted IMR90 cells 0.18
Cell cycle dynamics of human pluripotent stem cells primed for differentiation 0.17
System-wide profiling of RNA-binding proteins uncovers key regulators of virus infection 0.13
HIV Reprograms Human Airway Basal Stem/Progenitor Cells to Acquire a Tissue Destructive Phenotype 0.12
Identification of a unique gene expression signature in mercury and 2,3,7,8-tetrachlorodibenzo-p-dioxin co-exposed cells 0.11
Targets mediated microRNA arm-imbalance promotes gastric cancer progression [lncRNA] 0.08
RNA sequencing analysis of human podocytes reveals glucocorticoid regulated gene networks targeting non-immune pathways 0.05
RNA-seq analysis of BORIS/CTCFL knockdown in K562 cell line 0.04
RNA-seq and small RNA-seq analysis of BORIS/CTCFL knockdown in K562 cell line 0.04
Exogenous rescue of KLHL9 in SF210 cell line 0.0


Contact Us

For scientific and technical queries contact Butte Lab @UCSF


Cite GENEVA Tool

Manuscript in Preparation